66th PIHOA Executive Board Meeting

November 18-22, 2019
Honolulu, Hawaii
Mahalo and Thank You!

The PIHOA Secretariat and Executive Board Members wish to convey a heartfelt mahalo and thank you to all of you who were able to join us at the 66th PIHOA Executive Board Meeting in Honolulu, Hawaii!

Thank you all so much for all your comments, inputs, dialogue and feedback. We hope to see you all at the next PIHOA Meeting, tentative for March 2020.
Meeting Documents and Presentations
Day 3, Wednesday, November 20, 2019 (Open Session)

Communicable Diseases, Regional Epidemiology and Lab Capacity Strengthening, and Notifiable Disease Reporting


Grants and Quality Management/Improvement

Regional Human Resources for Health and Workforce Development


Integration of Primary Care and Population Health Services

  • Jurisdiction panels
Day 4, Thursday, November 21, 2019 (Open Session)
Centers for Disease Control (CDC) 
Update on CDC Priorities, Guidance to Improving NCD Patient Outcomes and Improving Environmental Health Practices in the Islands

Food and Drug Administration (FDA)
Update on FDA Priorities, Technical Assistance to Improve Food and Drug Security in the Islands and FDA Project Agreements/ Doc #2019-10-66  FDA-PIHOA Partnership Agreement
  • Mr. Timothy Mueller, JD, MAE, Director, Division of Integration, Office of Partnerships, Office of Regulatory Affairs, FDA HQ - Office of Partnerships Overview
  • Mr. Dan Solis, MHA, Program Division Director, Division of West Coast Imports, Office of Enforcement and Import Operations, Office of Regulatory Affairs, FDA R9/West Coast and Mr. Gordon Chu, Director of Investigations Branch, Division of West Coast Import (DWCI), Office of Enforcement and Import Operations, FDA R9/West Coast - FDA Office of Enforcement and Import Operations, Division of West Cost Imports
  • Zoom Connection Dr. Thomas Sidebottom, Director, San Francisco Laboratory, Office of Regulatory Science OFFLO, Office of Regulatory Affairs

Substance Abuse and Mental Health Services Administration (SAMHSA)
Update on SAMSHA Priorities, Island Perspective on Substance Abuse and Mental Health Issues – What’s Working and Preventing an Opioid Epidemic in the Islands.

University of Hawai’i Global Health/John A. Burns School of Medicine and Indo-PACOM 
Final report on results and recommendations from the UH-INDO-PACOM Partners Forum held on September 6, 2019 and discussion on strategic directions moving forward for capacity development support for the USAPIs.
  • RDML Louis Tripoli, MD, Command Surgeon, Indo-PACOM HQ, Camp Smith, Hawai’i and Dr. Lizette Durand, VMD, PhD, LTC/USPHS, US Health and Human Services (HHS)/Defense Threat Reduction Agency (DTRA) Health Security Liaison to Indo-PACOM, Office of Global Affairs, Office of the Secretary, HHS, Indo-PACOM HQ, Camp Smith, Hawai’i - Finding Sustainable Health Solutions for Oceania Roundtable
  • Dr. Neal Palafox, MD, MPH, Professor, Population Sciences in the Pacific Progam/Cancer Center and Department of Family Medicine and Community Health, University of Hawaii John A. Burns School of Medicine (UH JABSOM), Dr. Lee Buenconsejo-Lum, MD, Professor, Department of Family Medicine and Community Health and Director, Graduate Medical Education, UH JABSOM and Dr. Kristine Qureshi, PhD, RN, FAAN, CEN, PHNA-BC, Professor and Associate Dean for Research and Global Health Nursing, School of Nursing and Dental Hygiene, University of Hawai’i at Mānoa - Finding Sustainable Healthcare Solutions for Oceania Roundtable Follow-up

Strengthening USAPI Health Systems and Facilities (Medicaid and Compact Impact Financing)